UnitedHealth: Stock is on the rise again – should I get in now?

Shares of US health insurer UnitedHealth are approaching the end of a turbulent trading week. After temporarily plummeting by a third during the week, the price showed a significant recovery on Friday. But is now the right time for investors to get back in?

New allegations of fraud, the suspended annual forecast, and the change at the company's top management have had a negative impact on UnitedHealth shares this trading week (see related articles in the article box). As a result, the share price temporarily plummeted by around 34 percent, hitting a multi-year low of $248.88 on Thursday. However, after analysts at Morgan Stanley confirmed their buy rating, a slight countermovement began before the weekend.

However, with a gain of around six percent at times, the stock climbed to a daily high of $291.78 on Friday. This represents a recovery of around 17 percent from the multi-year low. However, the stock remains firmly trapped in a downtrend. Only a recapture of the resistance around the $430 mark would significantly brighten the chart picture.

In the latest episode of "Börsenpunk," Jochen Kauper analyzes the situation at UnitedHealth starting at minute 9:49. Learn how he assesses the situation and whether he thinks investors should reinvest in UnitedHealth after the share price slump. Berkshire Hathaway, Lotus Bakeries, Borussia Dortmund, Dürr, Volkswagen, Netflix, and numerous other stocks are also discussed in the video.